作者: Paven K. Aujla , Michael R. Fetell , Frances E. Jensen
DOI: 10.1111/J.1528-1167.2008.01947.X
关键词:
摘要: Purpose To test the efficacy of novel candidate anticonvulsant talampanel (GYKI 53773) in a rodent model hypoxic neonatal seizures. Talampanel is noncompetitive antagonist alpha-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid subtype glutamate receptor (AMPAR). We have previously shown that AMPARs play critical role generation acute seizures and later-life seizure susceptibility this